Patent application number | Description | Published |
20130018188 | PREPARATION OF ANHYDROUS AND HYDRATED POLYMORPHS OF 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-Q- UINOLIN-2-ONE-LACTIC ACID SALT - The present technology provides methods of making anhydrous crystalline Form II and monohydrate crystalline Form B of the lactic acid salt of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one. | 01-17-2013 |
20130123499 | Method for Purifying a Fused Pyrrolocarbazole Derivative - The present invention relates a method for purifying a fused pyrrolocarbazole compound known as 11-isobutyl-2-methyl-8-(2-pyrimidinylamino)-2,5,6,11,12,13-hexahydro-4Hindazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one using an acid complex thereof. The present invention also relates to a crystalline form of the acid complex. | 05-16-2013 |
20130245080 | BENZOTHIAZOLONE COMPOUND - The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form | 09-19-2013 |
20150094346 | BENZOTHIAZOLONE COMPOUND - The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form | 04-02-2015 |
20150336914 | BENZOTHIAZOLONE COMPOUND - The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form | 11-26-2015 |
20160075670 | BENZOTHIAZOLONE COMPOUND - The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form | 03-17-2016 |
20160128979 | MODIFIED RELEASE FORMULATION - Drug products in the form of modified release formulations comprising the drug substance (-)-(3aR,4S,7aR)-4-Hydroxy-4m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester (AFQ056), as well as processes for making such drug products are provided. The drug products are useful in treating patients with Parkinson's disease and exhibiting L-dopa induced dyskinesia. | 05-12-2016 |